By Design

With antibody-drug conjugates breaking new ground in oncology therapeutics, Trevor Hallam, Jeremy Bender and William Newell from Sutro Biopharma look at enhancements to the next generation of products.

Trevor Hallam, Jeremy Bender and William Newell, Sutro Biopharma (June 2014)

Keywords: Monoclonal antibodies, Site-specific conjugation, Non-natural amino acids

View full article    |    Back to Biopharma section